nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—osteoporosis—osteoarthritis	0.706	1	CtDrD
Raloxifene—ESR1—osteoarthritis	0.294	1	CbGaD
Raloxifene—AOX1—Tryptophan metabolism—ALDH1A2—osteoarthritis	3.11e-05	0.133	CbGpPWpGaD
Raloxifene—CYP19A1—Tryptophan metabolism—ALDH1A2—osteoarthritis	1.61e-05	0.0686	CbGpPWpGaD
Raloxifene—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	7.76e-06	0.0331	CbGpPWpGaD
Raloxifene—ESR2—Ovarian Infertility Genes—SMAD3—osteoarthritis	7.54e-06	0.0321	CbGpPWpGaD
Raloxifene—ESR2—Nuclear Receptors—ESR1—osteoarthritis	5.36e-06	0.0228	CbGpPWpGaD
Raloxifene—ESR2—Plasma membrane estrogen receptor signaling—ESR1—osteoarthritis	5.05e-06	0.0215	CbGpPWpGaD
Raloxifene—CYP2C8—Arachidonic acid metabolism—PTGES—osteoarthritis	4.82e-06	0.0205	CbGpPWpGaD
Raloxifene—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	4.7e-06	0.02	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	4.42e-06	0.0189	CbGpPWpGaD
Raloxifene—ESR2—Plasma membrane estrogen receptor signaling—IGF1—osteoarthritis	4.37e-06	0.0186	CbGpPWpGaD
Raloxifene—CYP19A1—Ovarian Infertility Genes—SMAD3—osteoarthritis	4.25e-06	0.0181	CbGpPWpGaD
Raloxifene—ESR2—Nuclear Receptor transcription pathway—ESR1—osteoarthritis	4.24e-06	0.0181	CbGpPWpGaD
Raloxifene—ESR2—Plasma membrane estrogen receptor signaling—MMP2—osteoarthritis	4.23e-06	0.018	CbGpPWpGaD
Raloxifene—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—osteoarthritis	3.53e-06	0.0151	CbGpPWpGaD
Raloxifene—ESR2—Plasma membrane estrogen receptor signaling—MMP9—osteoarthritis	3.18e-06	0.0135	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	3.08e-06	0.0131	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TIMP1—osteoarthritis	2.89e-06	0.0123	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—IL1RN—osteoarthritis	2.79e-06	0.0119	CbGpPWpGaD
Raloxifene—EBP—Metabolism—FMOD—osteoarthritis	2.42e-06	0.0103	CbGpPWpGaD
Raloxifene—CYP19A1—Biological oxidations—GSTO1—osteoarthritis	2.33e-06	0.00991	CbGpPWpGaD
Raloxifene—CYP19A1—Metapathway biotransformation—GSTO1—osteoarthritis	2.29e-06	0.00977	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL1A—osteoarthritis	2.22e-06	0.00945	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—IGF1—osteoarthritis	2.2e-06	0.00938	CbGpPWpGaD
Raloxifene—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—osteoarthritis	2.16e-06	0.00921	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—MMP2—osteoarthritis	2.13e-06	0.00908	CbGpPWpGaD
Raloxifene—ESR1—FOXM1 transcription factor network—MMP2—osteoarthritis	2.09e-06	0.00891	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—SMAD3—osteoarthritis	2.08e-06	0.00886	CbGpPWpGaD
Raloxifene—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—osteoarthritis	2.07e-06	0.00883	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—IHH—osteoarthritis	2e-06	0.00854	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTGES—osteoarthritis	1.97e-06	0.0084	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—IHH—osteoarthritis	1.83e-06	0.0078	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—osteoarthritis	1.81e-06	0.0077	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—MMP1—osteoarthritis	1.8e-06	0.00765	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	1.67e-06	0.0071	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—LEP—osteoarthritis	1.64e-06	0.007	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—MMP9—osteoarthritis	1.6e-06	0.00682	CbGpPWpGaD
Raloxifene—AOX1—Disease—FMOD—osteoarthritis	1.6e-06	0.00681	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—MMP2—osteoarthritis	1.59e-06	0.00679	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—GSTO1—osteoarthritis	1.49e-06	0.00636	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	1.47e-06	0.00628	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—GSTO1—osteoarthritis	1.47e-06	0.00628	CbGpPWpGaD
Raloxifene—AOX1—Disease—IHH—osteoarthritis	1.43e-06	0.00607	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GSTO1—osteoarthritis	1.39e-06	0.00591	CbGpPWpGaD
Raloxifene—EBP—Metabolism—BGN—osteoarthritis	1.34e-06	0.00573	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—FMOD—osteoarthritis	1.34e-06	0.00571	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—CXCL8—osteoarthritis	1.32e-06	0.00564	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	1.28e-06	0.00543	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	1.27e-06	0.0054	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GSTO1—osteoarthritis	1.26e-06	0.00539	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—GSTO1—osteoarthritis	1.25e-06	0.00531	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	1.21e-06	0.00514	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL1B—osteoarthritis	1.16e-06	0.00493	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—CXCL8—osteoarthritis	1.15e-06	0.00492	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—MCF2L—osteoarthritis	1.13e-06	0.00483	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	1.12e-06	0.00479	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	1.1e-06	0.00468	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTGES—osteoarthritis	1.09e-06	0.00465	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	1.08e-06	0.00462	CbGpPWpGaD
Raloxifene—AOX1—Disease—TGFBI—osteoarthritis	1.06e-06	0.00453	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	1.06e-06	0.00451	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—IL1B—osteoarthritis	1.05e-06	0.00446	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—MMP9—osteoarthritis	1.04e-06	0.00445	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—MCF2L—osteoarthritis	1.03e-06	0.00441	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MCF2L—osteoarthritis	1.03e-06	0.00438	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IHH—osteoarthritis	1.03e-06	0.00438	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	1e-06	0.00427	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	9.7e-07	0.00414	CbGpPWpGaD
Raloxifene—CYP2C8—Arachidonic acid metabolism—PTGS2—osteoarthritis	9.46e-07	0.00403	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MCF2L—osteoarthritis	9.39e-07	0.004	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IHH—osteoarthritis	9.39e-07	0.004	CbGpPWpGaD
Raloxifene—AOX1—Disease—GSTO1—osteoarthritis	9.18e-07	0.00391	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—SMAD3—osteoarthritis	8.97e-07	0.00382	CbGpPWpGaD
Raloxifene—AOX1—Disease—BGN—osteoarthritis	8.9e-07	0.00379	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—TGFB1—osteoarthritis	8.81e-07	0.00375	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	8.68e-07	0.0037	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TGFB1—osteoarthritis	8.6e-07	0.00367	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TNF—osteoarthritis	8.39e-07	0.00358	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTO1—osteoarthritis	7.69e-07	0.00328	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	7.64e-07	0.00326	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—BGN—osteoarthritis	7.45e-07	0.00317	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—IL6—osteoarthritis	7.43e-07	0.00317	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—ESR1—osteoarthritis	7.32e-07	0.00312	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	7.14e-07	0.00304	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—FMOD—osteoarthritis	6.93e-07	0.00295	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	6.89e-07	0.00294	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	6.79e-07	0.00289	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL6—osteoarthritis	6.77e-07	0.00289	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	6.69e-07	0.00285	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IL6—osteoarthritis	6.48e-07	0.00276	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	6.43e-07	0.00274	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MCF2L—osteoarthritis	6.08e-07	0.00259	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IHH—osteoarthritis	6.08e-07	0.00259	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGES—osteoarthritis	5.65e-07	0.00241	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IHH—osteoarthritis	5.55e-07	0.00236	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MCF2L—osteoarthritis	5.55e-07	0.00236	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	5.33e-07	0.00227	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MCF2L—osteoarthritis	4.62e-07	0.00197	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IHH—osteoarthritis	4.62e-07	0.00197	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	4.58e-07	0.00195	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—SMAD3—osteoarthritis	4.52e-07	0.00193	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—COL9A2—osteoarthritis	4.46e-07	0.0019	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—FMOD—osteoarthritis	4.45e-07	0.0019	CbGpPWpGaD
Raloxifene—AOX1—Disease—SMAD3—osteoarthritis	4.37e-07	0.00186	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—COL9A1—osteoarthritis	4.33e-07	0.00185	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—SMAD3—osteoarthritis	4.32e-07	0.00184	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	4.18e-07	0.00178	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—COL9A2—osteoarthritis	4.07e-07	0.00173	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTO1—osteoarthritis	3.98e-07	0.00169	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—COL9A1—osteoarthritis	3.95e-07	0.00168	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTGS2—osteoarthritis	3.87e-07	0.00165	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	3.85e-07	0.00164	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—BGN—osteoarthritis	3.85e-07	0.00164	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—FMOD—osteoarthritis	3.77e-07	0.0016	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGES—osteoarthritis	3.63e-07	0.00154	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	3.6e-07	0.00153	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—ESR1—osteoarthritis	3.52e-07	0.0015	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CXCL8—osteoarthritis	3.49e-07	0.00149	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IL6—osteoarthritis	3.49e-07	0.00149	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MMP3—osteoarthritis	3.48e-07	0.00148	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—COL9A2—osteoarthritis	3.39e-07	0.00145	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—COL9A1—osteoarthritis	3.29e-07	0.0014	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CXCL8—osteoarthritis	3.18e-07	0.00136	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MMP3—osteoarthritis	3.18e-07	0.00135	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	3.17e-07	0.00135	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGES—osteoarthritis	3.07e-07	0.00131	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—BMP2—osteoarthritis	2.97e-07	0.00126	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—BMP2—osteoarthritis	2.71e-07	0.00115	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTGS2—osteoarthritis	2.56e-07	0.00109	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTO1—osteoarthritis	2.55e-07	0.00109	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.49e-07	0.00106	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—BGN—osteoarthritis	2.47e-07	0.00105	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BMP2—osteoarthritis	2.26e-07	0.000962	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SMAD3—osteoarthritis	2.18e-07	0.000928	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTO1—osteoarthritis	2.16e-07	0.000922	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTGS2—osteoarthritis	2.14e-07	0.000913	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—BGN—osteoarthritis	2.09e-07	0.000892	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP3—osteoarthritis	2.06e-07	0.000877	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—FMOD—osteoarthritis	2.02e-07	0.000861	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCL8—osteoarthritis	1.97e-07	0.00084	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP3—osteoarthritis	1.88e-07	0.0008	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SMAD3—osteoarthritis	1.86e-07	0.000793	CbGpPWpGaD
Raloxifene—AOX1—Disease—TGFB1—osteoarthritis	1.85e-07	0.000788	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCL8—osteoarthritis	1.8e-07	0.000767	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCL8—osteoarthritis	1.79e-07	0.000763	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SMAD3—osteoarthritis	1.7e-07	0.000724	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGES—osteoarthritis	1.65e-07	0.000702	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCL8—osteoarthritis	1.63e-07	0.000696	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LEP—osteoarthritis	1.59e-07	0.000678	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP3—osteoarthritis	1.56e-07	0.000666	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ESR1—osteoarthritis	1.52e-07	0.000647	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FN1—osteoarthritis	1.5e-07	0.000639	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LEP—osteoarthritis	1.45e-07	0.000619	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SMAD3—osteoarthritis	1.42e-07	0.000603	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—osteoarthritis	1.39e-07	0.000594	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ESR1—osteoarthritis	1.39e-07	0.000591	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FN1—osteoarthritis	1.37e-07	0.000584	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.35e-07	0.000576	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1—osteoarthritis	1.31e-07	0.00056	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEP—osteoarthritis	1.21e-07	0.000516	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1—osteoarthritis	1.2e-07	0.000511	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTO1—osteoarthritis	1.16e-07	0.000495	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FN1—osteoarthritis	1.14e-07	0.000486	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BGN—osteoarthritis	1.12e-07	0.000479	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—osteoarthritis	1.11e-07	0.000472	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL8—osteoarthritis	1.06e-07	0.000451	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—osteoarthritis	1.01e-07	0.000428	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1—osteoarthritis	1e-07	0.000426	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL8—osteoarthritis	9.65e-08	0.000411	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—osteoarthritis	9.56e-08	0.000408	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—osteoarthritis	9.18e-08	0.000391	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—osteoarthritis	8.73e-08	0.000372	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL8—osteoarthritis	8.04e-08	0.000343	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—osteoarthritis	7.88e-08	0.000336	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—osteoarthritis	7.27e-08	0.00031	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—osteoarthritis	7.2e-08	0.000307	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—osteoarthritis	7.11e-08	0.000303	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—osteoarthritis	6.02e-08	0.000257	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—osteoarthritis	5.99e-08	0.000255	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—osteoarthritis	5.94e-08	0.000253	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—osteoarthritis	5.42e-08	0.000231	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—osteoarthritis	4.52e-08	0.000192	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—osteoarthritis	3.23e-08	0.000138	CbGpPWpGaD
